GMAB logo

Genmab A/S (GMAB) EBITDA

Annual EBITDA:

$1.08B+$255.98M(+31.24%)
December 31, 2024

Summary

  • As of today, GMAB annual EBITDA is $1.08 billion, with the most recent change of +$255.98 million (+31.24%) on December 31, 2024.
  • During the last 3 years, GMAB annual EBITDA has risen by +$556.10 million (+107.07%).
  • GMAB annual EBITDA is now at all-time high.

Performance

GMAB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABincome statement metrics

Quarterly EBITDA:

$380.81M+$176.67M(+86.54%)
June 1, 2025

Summary

  • As of today, GMAB quarterly EBITDA is $380.81 million, with the most recent change of +$176.67 million (+86.54%) on June 1, 2025.
  • GMAB quarterly EBITDA is now -42.75% below its all-time high of $665.22 million, reached on June 30, 2020.

Performance

GMAB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABincome statement metrics

TTM EBITDA:

$1.24B+$380.81M(+44.14%)
June 1, 2025

Summary

  • As of today, GMAB TTM EBITDA is $1.24 billion, with the most recent change of +$380.81 million (+44.14%) on June 1, 2025.
  • GMAB TTM EBITDA is now at all-time high.

Performance

GMAB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGMABincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

GMAB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+31.2%--
3Y3 Years+107.1%--
5Y5 Years+158.3%-42.8%+9.4%

GMAB EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+107.1%at high+86.5%at high+381.2%
5Y5-Yearat high+158.3%at high+179.4%at high+381.2%
All-TimeAll-Timeat high+883.4%-42.8%+743.1%at high+911.6%

GMAB EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$380.81M(+86.5%)
$1.24B(+44.1%)
Mar 2025
-
$204.14M(-38.2%)
$862.77M(+31.0%)
Dec 2024
$1.08B(+31.2%)
$330.27M(+0.6%)
$658.63M(+14.1%)
Sep 2024
-
$328.36M(+32.0%)
$577.08M(+13.8%)
Dec 2023
$819.51M(-12.0%)
$248.71M(-3.8%)
$507.15M(+96.2%)
Sep 2023
-
$258.44M(+79.7%)
$258.44M(-73.0%)
Dec 2022
$931.68M(+79.4%)
-
-
Dec 2021
$519.39M(-48.2%)
-
-
Dec 2020
$1.00B(+140.9%)
$143.84M(+5.5%)
$956.83M(-15.8%)
Sep 2020
-
$136.27M(-79.5%)
$1.14B(+7.9%)
Jun 2020
-
$665.22M(+5684.0%)
$1.05B(+157.0%)
Mar 2020
-
$11.50M(-96.4%)
$410.01M(+3.6%)
Dec 2019
$416.30M(+79.2%)
$323.55M(+507.3%)
$395.61M(+449.0%)
Sep 2019
-
$53.28M(+145.8%)
$72.06M(+283.6%)
Jun 2019
-
$21.68M(+848.8%)
$18.78M(+748.8%)
Mar 2019
-
-$2.90M(-253.0%)
-$2.90M(+84.8%)
Dec 2018
$232.36M(+8.4%)
-
-
Dec 2017
$214.40M(+31.9%)
-
-
Dec 2016
$162.51M(+86.5%)
-
-
Dec 2015
$87.12M(+76.4%)
-
-
Dec 2014
$49.38M(+242.8%)
-
-
Dec 2013
$14.40M(+182.2%)
-
-
Dec 2012
-$17.53M(+59.8%)
-$820.10K(+78.4%)
-$19.04M(+34.3%)
Sep 2012
-
-$3.80M(+45.8%)
-$28.96M(+18.2%)
Jun 2012
-
-$7.01M(+5.4%)
-$35.42M(+12.5%)
Mar 2012
-
-$7.41M(+31.0%)
-$40.47M(+7.6%)
Dec 2011
-$43.64M(>-9900.0%)
-$10.74M(-4.7%)
-$43.80M(+8.7%)
Sep 2011
-
-$10.26M(+15.0%)
-$47.99M(-548.8%)
Jun 2011
-
-$12.06M(-12.3%)
-$7.40M(+27.8%)
Mar 2011
-
-$10.74M(+28.0%)
-$10.25M(+59.7%)
Dec 2010
-$378.00K(+99.5%)
-$14.93M(-149.2%)
-$25.43M(-6904.6%)
Sep 2010
-
$30.34M(+303.4%)
-$363.00K(+99.5%)
Jun 2010
-
-$14.91M(+42.5%)
-$67.14M(+27.4%)
Mar 2010
-
-$25.92M(-355.8%)
-$92.49M(-13.8%)
Dec 2009
-$74.12M(+46.0%)
$10.14M(+127.8%)
-$81.29M(+46.0%)
Sep 2009
-
-$36.44M(+9.5%)
-$150.63M(-29.4%)
Jun 2009
-
-$40.27M(-173.7%)
-$116.41M(+9.8%)
Mar 2009
-
-$14.71M
-$129.00M
DateAnnualQuarterlyTTM
Dec 2008
-$137.28M(-75.5%)
-
-
Dec 2008
-
-$59.21M(-2571.8%)
-$153.23M(-29.4%)
Sep 2008
-
-$2.22M(+95.8%)
-$118.43M(+21.5%)
Jun 2008
-
-$52.86M(-35.8%)
-$150.94M(-51.4%)
Mar 2008
-
-$38.94M(-59.5%)
-$99.72M(-26.5%)
Dec 2007
-$78.24M(-1.4%)
-
-
Dec 2007
-
-$24.41M(+29.7%)
-$78.86M(+1.1%)
Sep 2007
-
-$34.72M(-2011.0%)
-$79.76M(-17.9%)
Jun 2007
-
-$1.64M(+90.9%)
-$67.63M(+16.5%)
Mar 2007
-
-$18.08M(+28.6%)
-$81.03M(-4.6%)
Dec 2006
-$77.13M(-17.1%)
-
-
Dec 2006
-
-$25.31M(-12.1%)
-$77.49M(-13.9%)
Sep 2006
-
-$22.59M(-50.1%)
-$68.05M(-11.9%)
Jun 2006
-
-$15.05M(-3.6%)
-$60.79M(+3.8%)
Mar 2006
-
-$14.53M(+8.5%)
-$63.20M(+4.1%)
Dec 2005
-$65.89M(+0.7%)
-
-
Dec 2005
-
-$15.88M(-3.5%)
-$65.89M(+6.2%)
Sep 2005
-
-$15.33M(+12.2%)
-$70.24M(+0.3%)
Jun 2005
-
-$17.46M(-1.4%)
-$70.42M(-1.5%)
Mar 2005
-
-$17.22M(+14.9%)
-$69.41M(-6.1%)
Dec 2004
-$66.38M(-55.2%)
-
-
Dec 2004
-
-$20.23M(-30.4%)
-$65.45M(-4.7%)
Sep 2004
-
-$15.51M(+5.7%)
-$62.51M(-2.6%)
Jun 2004
-
-$16.45M(-24.1%)
-$60.95M(-36.9%)
Mar 2004
-
-$13.26M(+23.3%)
-$44.53M(-3.8%)
Dec 2003
-$42.77M(+23.2%)
-
-
Dec 2003
-
-$17.29M(-23.9%)
-$42.92M(+8.4%)
Sep 2003
-
-$13.95M(>-9900.0%)
-$46.86M(-2.1%)
Jun 2003
-
-$24.90K(+99.8%)
-$45.91M(+19.0%)
Mar 2003
-
-$11.64M(+45.2%)
-$56.66M(-0.7%)
Dec 2002
-$55.72M(-117.8%)
-
-
Dec 2002
-
-$21.24M(-63.3%)
-$56.24M(-60.7%)
Sep 2002
-
-$13.00M(-20.7%)
-$35.00M(-59.1%)
Jun 2002
-
-$10.78M(+4.0%)
-$22.00M(-96.0%)
Mar 2002
-
-$11.22M(-239.3%)
-$11.22M(-239.3%)
Dec 2001
-$25.59M(-257.7%)
-
-
Mar 2001
-
-$3.31M
-$3.31M
Dec 2000
-$7.15M(-349.7%)
-
-
Dec 1999
-$1.59M
-
-

FAQ

  • What is Genmab A/S annual EBITDA?
  • What is the all-time high annual EBITDA for Genmab A/S?
  • What is Genmab A/S annual EBITDA year-on-year change?
  • What is Genmab A/S quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Genmab A/S?
  • What is Genmab A/S TTM EBITDA?
  • What is the all-time high TTM EBITDA for Genmab A/S?

What is Genmab A/S annual EBITDA?

The current annual EBITDA of GMAB is $1.08B

What is the all-time high annual EBITDA for Genmab A/S?

Genmab A/S all-time high annual EBITDA is $1.08B

What is Genmab A/S annual EBITDA year-on-year change?

Over the past year, GMAB annual EBITDA has changed by +$255.98M (+31.24%)

What is Genmab A/S quarterly EBITDA?

The current quarterly EBITDA of GMAB is $380.81M

What is the all-time high quarterly EBITDA for Genmab A/S?

Genmab A/S all-time high quarterly EBITDA is $665.22M

What is Genmab A/S TTM EBITDA?

The current TTM EBITDA of GMAB is $1.24B

What is the all-time high TTM EBITDA for Genmab A/S?

Genmab A/S all-time high TTM EBITDA is $1.24B
On this page